Literature DB >> 11487219

Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.

N Vanacore1, V Bonifati, G Fabbrini, C Colosimo, G De Michele, R Marconi, D Nicholl, N Locuratolo, G Talarico, S Romano, F Stocchi, U Bonuccelli, M De Mari, P Vieregge, G Meco.   

Abstract

Multiple system atrophy (MSA) is a form of atypical parkinsonism with unknown etiology. The epidemiological studies conducted up to now on this disease are scarce. The incidence rate is about 0.6 cases per 100,000 persons per year. The prevalence rates show 4-5 cases per 100,000 persons. In Italy, about 4,900 prevalent cases have been estimated. The mean onset age is about 54 years; the median survival is 7-9 years. Only one case-control study has been performed on this disease. This study showed an increased risk of MSA associated with occupational exposure to organic solvents, plastic monomers and additives, pesticides and metals. Smoking habits seem to be less frequent in MSA cases (as in Parkinson's disease cases) than in healthy controls. Quinn's clinical criteria and those of the Consensus Conference promoted by the American Academy of Neurology are in fair agreement. We have performed a case-control study on 73 MSA cases, 146 hospital controls and 73 population controls.

Entities:  

Mesh:

Year:  2001        PMID: 11487219     DOI: 10.1007/s100720170064

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

Review 1.  Confounders of vasovagal syncope: orthostatic hypotension.

Authors:  Victor C Nwazue; Satish R Raj
Journal:  Cardiol Clin       Date:  2013-02       Impact factor: 2.213

2.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

3.  Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.

Authors:  Yaroslav Winter; Maria Stamelou; Nicole Cabanel; Friedericke Sixel-Döring; Karla Eggert; Günter U Höglinger; Birgit Herting; Thomas Klockgether; Heinz Reichmann; Wolfgang H Oertel; Richard Dodel; Annika E Spottke
Journal:  J Neurol       Date:  2011-04-10       Impact factor: 4.849

4.  Association between parkinsonism and participation in agriculture in Korea.

Authors:  Jin-Whan Cho; Beom S Jeon; Dushin Jeong; Yoon-Jae Choi; Jun-Young Lee; Hae-Sung Lee; Sae-Yong Hong
Journal:  J Clin Neurol       Date:  2008-03-20       Impact factor: 3.077

5.  Sporadic ataxias in Japan--a population-based epidemiological study.

Authors:  Shoji Tsuji; Osamu Onodera; Jun Goto; Masatoyo Nishizawa
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 6.  Models of multiple system atrophy.

Authors:  Lisa Fellner; Gregor K Wenning; Nadia Stefanova
Journal:  Curr Top Behav Neurosci       Date:  2015

7.  The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

Authors:  Paul McCrone; Christine Anne Mary Payan; Martin Knapp; Albert Ludolph; Yves Agid; P Nigel Leigh; Gilbert Bensimon
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

8.  Multiple-system atrophy in long-term professional painter: a case report.

Authors:  Yusa Nagai; Riko Kitazawa; Miku Nakagawa; Munenori Komoda; Takeshi Kondo; Ryuma Haraguchi; Sohei Kitazawa
Journal:  Case Rep Pathol       Date:  2012-06-19

9.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

10.  Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls.

Authors:  S Fielding; A D Macleod; C E Counsell
Journal:  Parkinsonism Relat Disord       Date:  2016-08-12       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.